Sort by 'comments'
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management
Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to…
Next Generation Targeted Cancer Therapies – The Cellectar Story!
CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary…
COVID19 Pandemic – Impact on Pregnant Women and Those Seeking Infertility Treatments
Currently, very little is known about the impact of COVID-19 on reproduction and pregnancy. But as the COVID 19 pandemic began to affect lives around the world, out of an abundance of caution, the ASRM task force released a mandate…
Hepatitis C Infected Organ Transplant Offers Hope
Of the nearly 100,000 people waiting for a kidney transplant in the U.S., many will never get one. Meanwhile, hundreds of Hepatitis C infected organs are discarded because of the infection. The doctors at University of Pennsylvania connected these events…